Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists.
Koenig KL, Huang Y, Dotson EK, Sheredy S, Bhat SA, Byrd JC, Desmond E, Ford J, Iarocci S, Jones JA, Lucas MS, Moran ME, Wiczer TE, Woyach JA, Awan FT, Rogers KA.
Koenig KL, et al. Among authors: dotson ek.
Blood Adv. 2020 Oct 13;4(19):4860-4863. doi: 10.1182/bloodadvances.2020002593.
Blood Adv. 2020.
PMID: 33031541
Free PMC article.